Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: A gynecologic oncology group study

Cancer

Volumn 106, Issue 4, 2006, Pages 812-819

  Trimble, Cornelia L ^a   Kauderer, James ^b   Zaino, Richard ^c   Silverberg, Steven ^d   Lim, Peter C ^e   Burke II, James J ^f   Alberts, David ^g   Curtin, John ^h   Mackey, Denise ⁱ  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e Women's Cancer Center at Northern Nevada   (United States)

^f MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Four Penn Center   (United States)

Author keywords

Atypia; Biopsy; Consensus diagnosis; Endometrial hyperplasia; Endometrioid adenocarcinoma; Hysterectomy

Indexed keywords

GESTAGEN;

ADULT; AGED; ARTICLE; ATYPICAL ENDOMETRIUM HYPERPLASIA; CANCER INVASION; COHORT ANALYSIS; COMMUNITY HOSPITAL; CONSENSUS; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HOSPITALS, COMMUNITY; HUMANS; HYSTERECTOMY; MIDDLE AGED; PATIENT CARE PLANNING; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 32544432714     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21650     Document Type: Article

References (26)

1. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin. 1993;43:7-26.
2. Cavanagh D, Fiorica JV, Hoffman MS, Durfee J, Nicosia SV. Adenocarcinoma of the endometrium: an institutional review. Cancer Control. 1999;6:354-360.
3. Silverberg SG. Tumors of the uterine corpus and gestational trophoblastic disease. In: Silverberg S, Kurman RJ, editors. Atlas of tumor pathology, 3rd series, fascicle 3. Washington, DC: Armed Forces Institute of Pathology, 1992;13-14.
4. Mutter GL. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol. 2000;76:287-290.
5. Kurman R, Kaminski P, Norris H. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 1985;56:403-411.
6. Cullen T. Cancer of the uterus: its pathology, symptomatology, diagnosis, and treatment. New York: D. Appleton and Company, 1900.
7. Taylor H. Endometrial hyperplasia and carcinoma of the body of the uterus. Am J Obstet Gynecol. 1932;23:309-332.
8. Novak E, Yui E. Relationship of endometrial hyperplasia to adenocarcinoma of the uterus. Am J Obstet Gynecol. 1936;32 674-698.
9. Gusberg S. Precursors of corpus carcinoma: estrogens and adenomatous hyperplasia. Am J Obstet Gynecol. 1947;54:905-927.
10. Beutler HK, Dockerty MB, Randall LM. Precancerous lesions of the endometrium. Am J Obstet Gynecol. 1963;86:433-443.
11. Campbell PE, Barter RA. The significance of a typical endometrial hyperplasia. J Opt Soc Am. 1961;68:668-672.
12. Gusberg SB, Kaplan AL. Precursors of corpus cancer. IV. Adenomatous hyperplasia as Stage 0 carcinoma of the endometrium. Am J Obstet Gynecol 1963;87:662-678.
13. Gore H, Hertig AT. Carcinoma in situ of the endometrium. Am J Obstet Gynecol. 1966;94:134-155.
14. Vellios F. Endometrial hyperplasias, precursors of endometrial carcinoma. Pathol Annu. 1972;7:201-229.
15. Tavassoli F, Kraus FT. Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol. 1978;70:770-779.
16. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982;49:2547-2559.
17. Hendrickson MR, Kempson RL. The differential diagnosis of endometrial adenocarcinoma. Some viewpoints concerning a common diagnostic problem. Pathology. 1980;12:35-61.
18. Longacre TA, Chung MH, Jensen DN, et al. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol. 1995;19:371-406.
19. Skov BG, Broholm H, Engel U, et al. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. Int J Gynecol Pathol. 1997;16:33-37.
20. Bergeron C, Nogales FF, Masseroli M, et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol. 1999;23:1102-1108.
21. Kendall BS, Ronnett BM, Isacson C, et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol. 1998;22:1012-1019.
22. Janicek MF, Rosenshein NB. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia. Gynecol Oncol. 1994;52:373-378.
23. Dunton CJ, Baak JP, Palazzo JP, van Diest PJ, McHugh M, Widra EA. Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer. Am J Obstet Gynecol. 1996;174:1518-1521.
24. Mutter GL, Lin MC, Fitzgerald JT, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst. 2000;92:924-930.
25. Garcia FA, Davis JR, Alberts DS, et al. Nuclear chromatin patterns in normal, hyperplastic and atypical endometrium. Anal Quant Cytol Histol. 2001;23:144-150.
26. Bartels PH, Garcia FA, Davis J, et al. Progression curves for endometrial lesions. Anal Quant Cytol Histol. 2001;23:1-8.